# Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management

> **NCT04443608** · PHASE4 · TERMINATED · sponsor: **Comprehensive Research Associates** · enrollment: 115 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** Patiromer Powder for Oral Suspension [Veltassa]
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04443608
- **Lead sponsor:** Comprehensive Research Associates
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-08
- **Primary completion:** 2023-03-09
- **Final completion:** 2023-06-03
- **Target enrollment:** 115 (ACTUAL)
- **Why stopped:** Recruitment window ended
- **Last updated:** 2023-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04443608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04443608, "Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04443608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*